Popular terms

Respiratory topics
Respiratory
Ventilation
Respiratory Distress Syndrome
Executable
Computer Readable
Expiration
Respiration
Sleep Apnea
Medical Device
Continuous Positive Airway Pressure
Ventilator
Acute Respiratory Distress Syndrome
Antagonist
Cardiovascular Health
Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Respiratory patents



      

This page is updated frequently with new Respiratory-related patent applications.




Date/App# patent app List of recent Respiratory-related patents
07/21/16
20160208212 
 Method for the industrial production of flour from lipid-rich microalga biomass with no new patent Method for the industrial production of flour from lipid-rich microalga biomass with no "off-notes" by controlling the oxygen availability
The invention relates to a method for fermentative production, on an industrial scale, of lipid-rich biomass of microalgae of the chlorella genus having acceptable sensory properties, characterised in that the dissolved oxygen availability in the fermenter is controlled by tracking the respiratory quotient of said microalgae.. .
Roquette Freres


07/21/16
20160206875 
 Neurostimulation method and system to treat apnea patent thumbnailnew patent Neurostimulation method and system to treat apnea
Methods and systems are provided to deliver a neural stimulation therapy to treat apnea episodes. The methods and systems detect a respiratory pattern of a patient and identify a type associated with the respiratory pattern.
Pacesetter, Inc.


07/21/16
20160206843 
 Respiratory masks with gusseted cushions patent thumbnailnew patent Respiratory masks with gusseted cushions
A respiratory mask assembly for treatment of sleep disordered breathing includes a frame, a cushion which at least in part defines a cavity adapted to receive at least a patient's nose, and an air delivery connection supported by the frame and adapted to connect an air delivery conduit to supply air to the cavity. The cushion includes a face contacting portion, a non-face contacting portion, and a gusset portion between the face contacting portion and the non-face contacting portion, wherein the gusset portion includes a hanging portion that, when seen in cross-section, hangs over an adjacent exterior surface of the cushion, wherein the gusset portion includes a first point adjacent to the face contacting portion and a second point adjacent to the non-face contacting portion, and wherein the first point is offset radially outwardly from the second point..
Resmed Limited


07/21/16
20160206838 
 Respiratory knowledge portal patent thumbnailnew patent Respiratory knowledge portal
A monitoring system for multiple medical ventilators is provided. In one aspect, the monitoring system includes a memory that includes instructions, and a processor.
Carefusion 303, Inc.


07/21/16
20160206836 
 System and  aiding breathing patent thumbnailnew patent System and aiding breathing
A system for aiding breathing is provided. The system includes a breathing detection device, a sound-receiving device, an airflow providing device and a processing device.
Htc Corporation


07/21/16
20160206729 
 Immunogenic middle east respiratory syndrome coronavirus (mers-cov) compositions and methods patent thumbnailnew patent Immunogenic middle east respiratory syndrome coronavirus (mers-cov) compositions and methods
Disclosed herein are nanoparticles containing mers virus proteins in polymer structures, and compositions containing the nanoparticles formulated for administration as immunogenic compositions. Also provided herein are vector constructs encoding the proteins, and host cells containing the vector constructs.
Novavax, Inc.


07/21/16
20160206605 
 Compounds and methods for inhibiting cif virulence factor patent thumbnailnew patent Compounds and methods for inhibiting cif virulence factor
The present invention provides a screening assay for identifying inhibitors of pseudomonas aeruginosa cftr inhibitory factor as well as compositions and methods for ameliorating or treating a respiratory disease such as cystic fibrosis or secondary infection thereof.. .
The Regents Of The University Of California


07/14/16
20160202853 
 A user interface and  operating same patent thumbnailA user interface and operating same
A breathing apparatus with a user interface comprising a display for displaying at least one menu item, a first button operable to sequentially cycle through and display a plurality of menu items, a second and optionally third button operable to configure a parameter of the selected menu item, and a fourth button operable to confirm the change of a parameter of the selected menu item, wherein the parameter is a respiratory parameter and/or other breathing apparatus parameter.. .
Fisher & Paykel Healthcare Limited


07/14/16
20160200741 
 Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection patent thumbnailNovel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
Wherein r1, r2, r3, r4, r5, r7, a1, a2 and a3 are as described herein, compositions including the compounds and methods of using the compounds.. .

07/14/16
20160200718 
 New cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities patent thumbnailNew cyclohexylamine derivatives having ß2 adrenergic agonist and m3 muscarinic antagonist activities
The present invention relates to novel compounds having β2 adrenergic agonist and m3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.. .
Almirall, S.a.


07/14/16
20160199676 

Personal respiratory protection device


The present invention relates to a personal respiratory protection device, in particular, such a device comprising a respirator body having a periphery, a filter media, forming at least part of the respirator body, and a gasket, the gasket being located at the periphery and extending along at least a portion of its length.. .
3m Innovative Properties Company


07/14/16
20160199675 

Personal respiratory protection device


The present invention relates to a personal respiratory protection device, in particular, such a device comprising a respirator body having a periphery, a filter media, forming at least part of the respirator body, and a gasket, the gasket being located at the periphery and extending along at least a portion of its length.. .
3m Innovative Properties Company


07/14/16
20160199613 

Compressible respiratory therapy hose and collecting rod for storage


A compressible respiratory gas hose system interconnects a breathing gas source 101 and a patient interface device. The hose system has an open position when a breathing gas flow from the gas source is conducted to the patient interface device and a closed position when the gas flow is blocked.
Innotech Ltd


07/14/16
20160199612 

Outlet connection assembly and making the same


A connection assembly for a respiratory therapy system, comprising: an outlet assembly, said outlet assembly including an outlet housing and a swivelling disc located on said outlet housing, said outlet housing and said swivelling disc defining, at least in part, a recess; an outlet connector located at an end of a tube portion, said outlet connector including an electrical connector; and a cable having a first end to connect to the electrical connector and a second end to connect to at least one electrical component of the respiratory therapy system, said cable having a slack portion, wherein said outlet connector and said swivelling disc are rotatable in unison between a first position and a second position, and wherein the slack portion of the cable extends from the recess and wraps around the swivelling disc as the swivelling disc is rotated from the first position to the second position.. .
Resmed Limited


07/14/16
20160199610 

Nasal interface


A nasal cannula for use in a system for providing a flow of respiratory gases to a user is described. The nasal cannula comprises a body made from a pliable material.
Fisher & Paykel Healthcare Limited


07/14/16
20160199609 

Respiratory interface


A patient respiratory interface for use in an aerosol delivery system is disclosed. The interface may provide a mechanism for introducing an aerosolized medicament to infants without the need for invasive intubation when treating issues in infants such as infant respiratory distress syndrome.
Trudell Medical International


07/14/16
20160199607 

Respiratory therapy apparatus


A blower comprises a housing, an inlet to receive air, an outlet to deliver a flow of air and a deformable member configured to pump a chamber. The deformable member may be configurable to a first configuration and a second configuration, for example by electrical energy that may be applied as current or voltage.
Resmed Limited


07/14/16
20160199605 

Gas therapy system


A flow generator for use in respiratory therapy can be constructed with a housing. A support fixation arrangement can be fixed to the housing.
Fisher & Paykel Healthcare Limited


07/14/16
20160199604 

Inhalation therapy device for use in premature babies and infants


For use in premature babies and infants, in particular for administering surfactant to the lungs, the inhalation therapy device described herein comprises an aerosol generating device 1, a respiratory air flow generating means 3 and a nebulising chamber 5 into which the generated liquid droplets 2 and the respiratory air flow 4 are supplied. The nebulising chamber 5 comprises a tapering area 52 which ends in a tubular intubation means 6.
Pari Pharma Gmbh


07/14/16
20160199477 

Attenuated mannheimia haemolytica vaccines and methods of making and use


The present invention provides attenuated m. Haemolitica strains that elicit an immune response in animal against m.
Merial Inc.


07/14/16
20160199413 

Mscs in the treatment of inflammatory pulmonary diseases


The present invention relates to, inter alia, methods for culturing mesenchymal stem cells (mscs) (without the use of non-human serum components), mscs and extracellular vesicles obtained from such culturing methods, having advantageous polypeptide profiles which are key for immuno-modulatory efficacy. Further, the present invention pertains to pharmaceutical compositions comprising such mscs and/or extracellular vesicles, and medical treatment and prophylactic methods and medical uses of mscs and/or extracellular vesicles in a variety of diseases, notably acute respiratory distress syndrome (ards), infant respiratory distress syndrome (irds), pulmonary hypertension (ph), and related diseases and ailments, such as organ failure..
Isletone Ab


07/14/16
20160199253 

Automated ventilator with assisted compressions


A system for performing simultaneous ventilation and resuscitation of a patient includes an oxygen source, at least one inspiration control valve, a breathing apparatus, at least one expiration control valve, at least one indicator, and at least one timer. The breathing apparatus is configured to form an air seal with at least a portion of the patient's respiratory tract such that a gas including oxygen can flow from the oxygen source to the lungs.

07/07/16
20160194387 

Methods of treating inflammation associated airway diseases and viral infections


The present disclosure provides methods of treating a pathogen-induced lung inflammation in a subject are provided in which an anti-s100a9 antibody is administered to a subject. Methods of treating a respiratory virus infection by administering an anti-s100a9 antibody are also provided..
The Board Of Regents Of The University Of Texas System


07/07/16
20160194383 

Anti-human respiratory syncytial virus (rsv) antibodies and methods of use


Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (f) protein of respiratory syncytial virus (rsv). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of rsv-mediated disease.
Crucell Holland B.v.


07/07/16
20160193486 

Personal respiratory protection device


The present invention relates to a personal respiratory protection device, in particular, such a device comprising a respirator body having a periphery, a filter media, forming at least part of the respirator body, and a gasket, the gasket being located at the periphery and extending along at least a portion of its length.. .
3m Innovative Properties Company


07/07/16
20160193438 

Improvements to flow therapy


A method of estimating a parameter indicative of respiratory flow of a patient being administered flow therapy, comprising: optionally administering a gas at a flow rate to the patient using a flow therapy apparatus with a patient interface, determining a terminal pressure in, at or proximate the outlet of the patient interface or in, at or proximate the nares of the patient, determining nasal rtf, determining a nasal flow parameter being or indicative of nasal flow based on the pressure and a nasal rtf, and optionally outputting the nasal flow parameter or parameter derived therefrom.. .
Fisher & Paykel Healthcare Limited


07/07/16
20160193437 

Control for respiratory device


The operational parameters of a respiratory apparatus can be controlled through the use of a user interface located on a separate or separable mobile computing device. Sensors or features located on the mobile computing apparatus can be used to adjust the operation parameters or therapy of the respiratory apparatus or otherwise improve the compliance of a patient utilizing the respiratory apparatus..
Fisher & Paykel Healthcare Limited


07/07/16
20160193436 

Respiratory therapy apparatus, sensors and methods


respiratory therapy apparatus includes an expiratory vibratory therapy device (100) of the kind that produces an alternating resistance to expiration through the device. The apparatus also includes a sensor (30) that is strapped to the chest of the patient.
Smiths Medical International Limited


07/07/16
20160193327 

Mucosal vaccine composition


The present invention aims at providing a mucosal vaccine composition that can be administered to an intraoral mucous membrane, ocular mucous membrane, ear mucous membrane, genital mucous membrane, pharyngeal mucous membrane, respiratory tract mucous membrane, bronchial mucous membrane, pulmonary mucous membrane, gastric mucous membrane, enteric mucous membrane, or rectal mucous membrane, that is useful as a prophylactic or therapeutic agent for infectious diseases or cancers, and is capable of safely and effectively inducing the systemic immune response and mucosal immune response. The present invention provides a mucosal vaccine composition to be administered to at least one mucous membrane selected from the group consisting of a human or animal intraoral mucous membrane, ocular mucous membrane, ear mucous membrane, genital mucous membrane, pharyngeal mucous membrane, respiratory tract mucous membrane, bronchial mucous membrane, pulmonary mucous membrane, gastric mucous membrane, enteric mucous membrane, and rectal mucous membrane, containing: at least one antigen; and as an adjuvant, a lipopolysaccharide derived from at least one gram-negative bacterium selected from the group consisting of serratia, leclercia, rahnella, acidicaldus, acidiphilium, acidisphaera, acidocella, acidomonas, asaia, belnapia, craurococcus, gluconacetobacter, gluconobacter, kozakia, leahibacter, muricoccus, neoasaia, oleomonas, paracraurococcus, rhodopila, roseococcus, rubritepida, saccharibacter, stella, swaminathania, teichococcus, zavarzinia, pseudomonas, achromobacter, bacillus, methanoculleus, methanosarcina, clostridium, micrococcus, flavobacterium, pantoea, acetobacter, zymomonas, xanthomonas, and enterobacter, or a salt thereof..
Nitto Denko Corporation


07/07/16
20160193248 

Methods for improving respiratory system health and increasing the concentration of hypothiocyanate ion in vertbrate lungs


The present disclosure relates to methods and devices to improve respiratory system health, increase resistance to infection, and increase the hypothiocyanate ion in mammalian lungs. The methods generally comprise: generating a hydrogen peroxide gas that is non-hydrated and free of ozone, and directing the gas comprising primarily hydrogen peroxide gas into an environment and exposing a subject to the environment such that the hydrogen peroxide gas acts to the increase of the hypothiocyanate ion in mammalian lungs..

07/07/16
20160192893 

Blood flow control in-vivo imaging and other applications


A method of and device for acquiring in-vivo images or quantitative/qualitative data (perfusion, blood flow, vascularization, contrast enhancement, selective blood supply management) of interior parts of the human body (20) is described, using an imaging system (21) and including the steps of positioning the body (20) relatively to the imaging system (21), applying a respiratory resistance device (10) to the respiratory system of the body (20), and performing an image acquisition step during or concomitantly an inhalation/inspiration/suction or exhalation/valsalva/expiration phase, during which the body provides suction or exhalation against a resistance as provided by the respiratory resistance device (10).. .

06/30/16
20160184636 

Method for developing individualized athletic training program


The ability to use data from tests of maximum aerobic capacity to determine the ventilatory threshold and point of respiratory compensation (rcp) is useful for coaches, athletes, and other disciplines in the development of training schemes. Current methods for determining the rcp generally involve identifying deflections in respiratory variables when examined along minute ventilation.

06/30/16
20160184617 

Personal respiratory protection device


The present invention relates to a personal respiratory protection device, in particular, such a device comprising a respirator body having a periphery, a filter media, forming at least part of the respirator body, and a gasket, the gasket being located at the periphery and extending along at least a portion of its length.. .

06/30/16
20160184538 

Detecting the fit of a patient interface device


A method of detecting the fit of a patient interface device (8) includes determining a plurality of capacitance values when the patient interface device is donned by a user. The patient interface device has a contacting element (14) having a user contacting surface (49), and each of the capacitance values is associated with one of a plurality of locations along at least a portion of the contacting surface, wherein each of the locations has a number of electrode elements (54) associated therewith that are used to determine the capacitance values.

06/30/16
20160184518 

Respiratory parameter guided automated iv administration and iv tube clamp activation


Disclosed is a system that includes a sensor for acquiring a physiological bioelectrical impedance signal from a patient functionally connected to the computing device. The computing device preferably analyzes the physiological bioelectrical impedance signal and provides outputs an assessment of minute ventilation of the patient based on the analyzed bioelectrical impedance signal.

06/30/16
20160184377 

Method for promoting respiratory burst activity promoter and immunostimulating in type 2 diabetic patients


To confirm the safety of a fermented papaya preparation in type 2 diabetic patients while determining its in vivo effect on respiratory burst in human peripheral-blood mononuclear cells to find further health advantages for the type 2 diabetic patients. A respiratory burst activity promoter for improving the production of reactive oxygen species (ros) induced by nadph oxidase and promoting respiratory burst activity in type 2 diabetic patients, comprising a fermented papaya preparation as an active ingredient..

06/30/16
20160183846 

Processing apparatus and processing determining a respiratory signal of a subject


A processing apparatus (6) for determining a respiration signal (34) of a subject (100) is presented. The processing apparatus (6) is configured to perform the steps of obtaining a movement signal (22) descriptive of a respiratory movement, determining a first quantity (24) descriptive of a rotation axis and/or rotation angle based on the obtained movement signal (22), and estimating a rotation axis (25) and/or rotation angle (26) based on the first quantity (24) and a rotation model, wherein the rotation model models the respiratory movement as a rotation around a single rotation axis.

06/23/16
20160176932 

Stabilized soluble pre-fusion rsv f polypeptides


This disclosure provides stable pre-fusion respiratory syncytial virus (rsv) f polypeptides, immunogenic compositions comprising the polypeptides, and uses thereof for the prevention and/or treatment of rsv infection.. .

06/23/16
20160175556 

Breathing assistance device comprising a gas regulating valve and associated breathing assistance method


The invention relates to a breathing assistance device for a patient, the device including: a source of respiratory pressurised gas; a gas transmission duct comprising a distal end coupled to said source and a proximal end coupled to the patient; a gas regulating valve interposed in the gas transmission duct at a proximal location, comprising a leakage orifice and an obstruction means capable of varying the opening of the leakage orifice upon signal of controlling means and allowing a bidirectional gas flow through the leakage orifice in both expiration and inspiration phases.. .

06/23/16
20160175245 

Treatment of diseases associated with mold and mycotoxin exposure


A method of treating disease states associated with mold and mycotoxin , resulting in illnesses such as chronic fatigue syndrome (cfs), gulf war syndrome (gws), fungal sinusitis, rhino sinusitis, chronic rhino sinusitis (crs), abnormalities in t and b cells, central and peripheral nervous system disorders, asthma, sarcoidosis, respiratory infections, fibromyalgia, headache, depression, autoimmune disorders, and cancer, among others, comprising delivery of a medication to the nasal passages and/or sinus cavities of a patient, wherein the medication comprises an antifungal agent.. .

06/23/16
20160174903 

System and outpatient management of chronic disease


An outpatient ambulatory patient worn apparatus for managing chronic lung disease includes a plurality of sensors configured to be worn by a patient and to measure a plurality of physiological data. The plurality of sensors includes at least an oximeter, a respiratory rate sensor, and at least one activity or motion sensor.

06/23/16
20160174875 

Assembly for the extraction of respiratory gas samples


An assembly for the extraction of respiratory gas samples may include a container for receiving a respiratory gas sample, a piston arranged in the container in a movable and gas-sealing manner, and a gas feed into the container, which gas feed can be connected to a mouthpiece.. .

06/16/16
20160169889 

Diagnosis of respiratory tract infectious disease using urine specimens


Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in that a measured value of scd14-st in urine is used as an indication.. .
Mochida Pharmaceutical Co., Ltd.


06/16/16
20160168207 

Respiratory syncytial virus (rsv) vaccine


The present invention relates to an mrna sequence, comprising a coding region, encoding at least one antigenic peptide or protein of rsv infections respiratory syncytial virus (rsv) or a fragment, variant or derivative thereof. Additionally the present invention relates to a composition comprising a plurality of mrna sequences comprising a coding region, encoding at least one antigenic peptide or protein of rsv infections respiratory syncytial virus (rsv) or a fragment, variant or derivative thereof.
Curevac Ag


06/16/16
20160168124 

Substituted pyridine-piperazinyl analogues as rsv antiviral compounds


The invention concerns novel substituted pyridine-piperazinyl analogues of formula (i) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (rsv). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection..
Janssen Sciences Ireland Uc


06/16/16
20160166970 

Filtering material and use thereof


The present invention relates to an adsorptive filter unit (i.e. A filter structure or filter media, respectively), which is especially intended for the purification of gases and/or gas mixtures, preferably air, and/or for the removal of chemical and/or biological substances or noxiants from gases and/or gas mixtures, preferably air, in particular for use in or as a respiratory filter or gas-mask filter..
Blücher Gmbh


06/16/16
20160166798 

Mouthpiece for controlled delivery of a breathing gas


The present invention relates to a mouthpiece for controlled delivery of a breathing gas including oxygen, preferably an increased ratio of oxygen with respect to ambient air, to the respiratory tracts of a user comprising a valve having two modes; a closed default mode, which substantially impedes any flow of the breathing gas through the valve; and an active open mode, which allows for a substantial flow of the breathing gas through the valve, wherein the open mode can be activated by the user manipulating the valve with his/her mouth. The invention also relates to the use of such a valve in a device for delivery of breathing gas and further to an apparatus for controlled delivery of the breathing gas to the respiratory tracts of a user.
Resmed R&d Germany Gmbh


06/16/16
20160166795 

Device, system and positive pressure ventilation (ppv) resuscitation to continuous positive airway pressure (cpap)


The resuscitation method and device incorporates a t-piece and/or bag and mask resuscitation device that transforms into short term (and then long term) cpap device. This results in continuum of respiratory care in the delivery room, and potentially in the nursery.
General Electric Company


06/16/16
20160166790 

Ultrasonic measurements for monitoring patients using respiratory therapy delivery devices


Systems and methods for delivering therapy and/or medicament to a subject use one or more sensors to generate signals that represent characteristics of ultrasonic energy emitted during the use of respiratory medicament delivery devices. Parameters based on these signals indicate energy amplitude in one or more frequency ranges.
Koninklijke Philips N.v.


06/16/16
20160166787 

Monitoring respiratory parameters through ultrasonic measurements indicating flow changes in respiratory drug delivery devices


Systems and methods for delivering medicament to a subject use one or more sensors to generate signals that represent characteristics of the ultrasonic energy emitted into or by a respiratory medicament delivery device. Parameters based on these signals indicate energy amplitude in one or more frequency ranges.
Koninklijke Philips N.v.


06/16/16
20160166621 

Non-chemotherapeutic antibiotic treatment for infections in cattle


Compositions and methods for treating and/or preventing bacterial infections in animals such as bovines are provided. The compositions and methods utilize the predatory bacterium bdellovibrio bacteriovorus to treat and/or prevent infections such as infectious bovine keratoconjunctivitis (ibk) and bovine respiratory disease (brd).
The Board Of Regents Of The University Of Oklahoma


06/16/16
20160166520 

Methods and compositions relating to the treatment of visceral fat and asthma


The technology described herein is directed to methods of treating, e.g., obesity and/or asthma which relate to the interacting roles of chi3l1 and sirt1 in controlling adipose tissue and respiratory health.. .
Yale University


06/16/16
20160166505 

Methods and compositions for treatment of respiratory tract infections


A method of treating a patient for an upper or lower respiratory tract infection includes mixing a dry powder pharmaceutical composition including tobramycin with a base liquid to produce a nebulizer solution dosage form. The method may further include encapsulating the powder in a capsule and dispensing the capsule for the subsequent mixing of the powder with the base prior to administration to the patient via intranasal nebulization..
Cmpd Licensing, Llc


06/16/16
20160166176 

Computer-based analysis of oscillatory ventilation


This document provides systems and techniques that can be used to provide computer-implemented interpretation (e.g., up-to-date, on demand, and real time interpretation) of respiratory profiles of patients using, for example, an application provided by a computer server system, to assess a patient's cardiac and/or pulmonary function.. .
Mayo Foundation For Medical Education And Research


06/16/16
20160166175 

Determining respiratory gas exchange in a subject


The present disclosure provides examples of a method, including: providing a representative inhale-exhale cycle breathing volume over time profile; and when the subject performs at least one inhale-exhale cycle that meets a correspondence criterion related to the representative profile, using data relating to oxygen consumption or carbon dioxide production during the inhale-exhale cycle that met the correspondence criterion to determine a metabolic property in the subject.. .
Meta Flow Ltd.


06/16/16
20160165972 

Sleep apnea prevention mask


A sleep apnea prevention sleep-aid mask is described. The sleep-aid mask is configured to secure the lips of a user together in a natural state, in order to encourage the respiratory system of the user to employ the nasal passages rather than the mouth for respiration.

06/16/16
20160165960 

Expandable three in one swaddler


A swaddler which is suitable for a child from birth until when the baby rolls over. It has two interior pockets and a removable seam to extend its length, allowing for a better sized fit during baby growth stages.
Brownmed, Inc.


06/09/16
20160165387 

Smart home platform with data analytics for monitoring and related methods


A smart home system with data analytics for home monitoring or for monitoring enclosed spaces other than the home. The system can include a ble mesh network with an embedded gateway and a plurality of repeater nodes running ble mesh software for use with a cloud server for receiving data from the gateway through wifi communication.

06/09/16
20160161506 

Diagnosis of respiratory tract infectious disease using blood specimens


Provided are a method for detecting respiratory infection associated with bacterial infection, a method for selecting patients with respiratory infection to receive an antibiotic, and a method for determining the timing for ending administration of an antibiotic to a patient with respiratory infection receiving the antibiotic, wherein said methods are characterized in that they are able to appropriately select patients with respiratory infection to whom the antibiotic is to be administered, to adjust the administration period of the antibiotic, and to treat respiratory infection associated with bacterial infection, and in which a measured value of scd14-st in blood is used as an indication.. .
Mochida Pharmaceutical Co., Ltd.


06/09/16
20160161505 

Diagnosis and risk stratification using nt-proet-1


The invention relates to a method for the diagnosis and/or risk stratification of cardiac diseases and diseases of the respiratory tract and lungs. According to said method, the free fragment n-terminal proendothelin (nt-proet-1; amino acids 18-52 of the preproet according to fig.
Brahms Gmbh


06/09/16
20160159886 

Stabilized liquid anti-rsv antibody formulations


The present invention provides liquid formulations of synagis® or an antigen-binding fragment thereof that immunospecifically bind to a respiratory syncytial virus (rsv) antigen, which formulation exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of synagis® or an antigen-binding fragment thereof, even during long periods of storage. In particular, the present invention provides liquid formulations of synagis® or an antigen-binding fragment thereof which immunospecifically binds to a rsv antigen, which formulation are substantially free of surfactant, inorganic salts, and/or other common excipients furthermore, the invention provides method of preventing, treating or ameliorating symptoms associated with rsv infection utilizing liquid formulations of the present invention..
Medimmune, Llc


06/09/16
20160159870 

Compositions and methods of use for recombinant human secretoglobins


Methods of synthetically producing, formulating and using secretoglobins scgb1a1, scgb3a2, and scgb3a1 are provided. Methods of using secretoglobins scgb1a1, scgb3a2, and scgb3a1 as therapeutic agents to affect long term patient outcomes, such as preventing severe respiratory exacerbations of underlying conditions that require medical intervention, including hospitalization are provided.
Therabron Therapeutics, Inc.


06/09/16
20160159794 

Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection


Wherein r1, r2, r3, r4, r5, w and x are as described herein, compositions including the compounds and methods of using the compounds.. .

06/09/16
20160159793 

Fused pyrroledicarboxamides and their use as pharmaceuticals


The present invention relates in fused pyrroledicarboxamides of the formula (i), in which r1 to r9, x, m and n are as defined in claims. The compounds of the formula (i) are inhibitors of the acid-sensitive potassium channel task-1 and suitable for the treatment of task-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example..
Sanofi




Respiratory topics: Respiratory, Ventilation, Respiratory Distress Syndrome, Executable, Computer Readable, Expiration, Respiration, Sleep Apnea, Medical Device, Continuous Positive Airway Pressure, Ventilator, Acute Respiratory Distress Syndrome, Antagonist, Cardiovascular Health, Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Respiratory for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Respiratory with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.4008

5405

469493 - 0 - 104